News

Cannabis stocks extended their early losses Wednesday, as investors weighed the surprise news that the head of the U.S. Food and Drug Administration has resigned, leaving the fate of the cannabis ingredient CBD in regulatory limbo. Commissioner Scott Gottlieb, known for his efforts to stem teen vaping, will step down next month after two years in the role. Just last week, Gottlieb said public meetings will be held sometime in April to hear from relevant parties on how best to regulate CBD derived from hemp, which was legalized in December in the 2018 Farm Bill. The FDA is responsible for regulating CBD, a non-psychoactive...